AnaptysBio (ANAB) stock price, revenue, and financials

AnaptysBio market cap is $730.2 m, and annual revenue was $8 m in FY 2019

$730.2 M

ANAB Mkt cap, 23-Feb-2021
AnaptysBio Net income (Q3, 2020)-23.8 M
AnaptysBio EBIT (Q3, 2020)-24.3 M
AnaptysBio Cash, 30-Sept-2020209.2 M
AnaptysBio EV521.9 M

AnaptysBio Income Statement

Annual

USDFY, 2017FY, 2018FY, 2019

Revenue

10.0m5.0m8.0m

R&D expense

29.4m56.2m99.3m

General and administrative expense

9.3m15.5m16.1m

Operating expense total

38.8m71.7m115.4m

EBIT

(28.8m)(66.7m)(107.4m)

EBIT margin, %

(288%)(1334%)(1343%)

Interest income

1.6m6.7m11.0m

Pre tax profit

(30.1m)(61.8m)(97.5m)

Income tax expense

(192.0k)(152.0k)

Net Income

(30.1m)(61.7m)(97.3m)

AnaptysBio Balance Sheet

Annual

USDFY, 2017FY, 2018FY, 2019

Cash

81.2m113.6m171.0m

Accounts Receivable

Prepaid Expenses

2.7m7.0m3.5m

Current Assets

252.7m434.2m377.7m

PP&E

665.0k1.4m1.6m

Total Assets

329.4m509.0m435.2m

Accounts Payable

2.3m5.4m16.2m

Short-term debt

6.9m7.6m2.2m

Current Liabilities

14.1m21.8m29.5m

Long-term debt

654.0k

Total Debt

6.9m7.6m2.9m

Common Stock

24.0k27.0k27.0k

Additional Paid-in Capital

393.0m633.3m648.7m

Retained Earnings

(85.0m)(146.7m)(244.0m)

Total Equity

307.6m486.4m405.0m

Financial Leverage

1.1 x1 x1.1 x

AnaptysBio Ratios

USDQ1, 2017

Financial Leverage

1.2 x

AnaptysBio Employee Rating

3.813 votes
Culture & Values
3.5
Work/Life Balance
3.8
Senior Management
3.2
Salary & Benefits
3.8
Career Opportunities
3.4
Source